Benzetimide,
Dexbenzetimid,
Dexbenzetimide,
Dexetimide,
dextro Benzetimide,
dextro-Benzetimide,
R 16470,
R-16470,
R16470,
Spasmentral,
Tremblex,
BENZETIMIDE HYDROCHLORIDE,
Benzetimide HCl,
Spasmentral,
Dioxatrine,
5633-14-7,
Benzetimide (hydrochloride),
McN-JR4929,
McN-JR 4929,
Benzetimide hydrochloride [USAN],
EINECS 227-072-8,
R 4929,
MCN-JR-4929-11,
2-(1-Benzyl-4-piperidyl)-2-phenylglutarimide monohydrochloride,
dl-2-(1-Benzyl-4-piperidyl)-2-phenylglutarimide hydrochloride,
dl-1-Benzyl-4-(2,6-dioxo-3-phenyl-3-piperidyl)piperidine hydrochloride,
Benzetimide hydrochloride (USAN),
Glutarimide, 2-(1-benzyl-4-piperidyl)-2-phenyl-, hydrochloride,
3-Phenyl-1'-(phenylmethyl)(3,4'-bipiperidine)-2,6-dione monohydrochloride,
(3,4'-Bipiperidine)-2,6-dione, 3-phenyl-1'-(phenylmethyl)-, monohydrochloride,
C23H26N2O2.HCl,
Dioxatrine (TN),
Janssen R-4929,
R 16470 hydrochloride,
(+)-DEXETIMIDE,
AC1L2J7M,
JANSSEN R 4929,
MLS001201802,
SCHEMBL635393,
CHEMBL545131,
CTK8H6259,
HY-B1547A,
BCP11991,
dexetimide hydrochloride hydrochloride,
AKOS025402010,
CS-5308,
AC-28141,
LS-72019,
SMR000718634,
D03087,
1'-benzyl-3-phenyl-3,4'-bipiperidine-2,6-dione hydrochloride,
3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione hydrochloride,
3-phenyl-1 -(phenylmethyl)-[3,4 -bipiperidine]-2,6,-dione hydrochloride,
3-phenyl-1'-(phenylmethyl)-[3,4'-bipiperidine]-2,6,-dione hydrochloride,
Benzetimide,
UNII-V6ERX20PHB,
V6ERX20PHB,
D09DIB,
C23H26N2O2.ClH,
CID21846,
C23-H26-N2-O2.Cl-H,
RG-4929,
RO-5093151,
R-4929,
2-[1-BENZYL-4-PIPERIDYL]-2-PHENYLGLUTARIMIDE,
11-beta HSD inhibitor (type 2 diabetes), Roche,
2-[1-BENZYL-4-PIPERIDYL]-2-PHENYLGLUTARIMIDE HCl,
11-beta hydroxysteroid dehydrogenase inhibitor (type 2 diabetes), Roche,
3-phenyl-1'-(phenylmethyl)[3,4'-bipiperidine]-2,6-dione monohydrochloride,
[3,4'-Bipiperidine]-2,6-dione, 3-phenyl-1'-(phenylmethyl)-,monohydrochloride,